PATIENCE WADDELL: Open Payments
NPI 1063020469 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 27 payments from 10 companies in 2025. Trend: 2023 $153 · 2024 $494 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $183 |
| PFIZER INC. | 2 | $134 |
| ABBVIE INC. | 1 | $119 |
| Madrigal Pharmaceuticals | 4 | $96 |
| Celltrion USA Inc. | 4 | $63 |
| Novo Nordisk Inc | 2 | $32 |
| Lilly USA, LLC | 2 | $31 |
| Janssen Biotech, Inc. | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Ardelyx, Inc. | 1 | $19 |
Products named: ENTYVIO, VELSIPITY, CREON, REZDIFFRA, VEGZELMA, Wegovy, OMVOH, EOHILIA.
Industry payments across TN — which companies pay providers there.
